0001209191-21-041176.txt : 20210616 0001209191-21-041176.hdr.sgml : 20210616 20210616202129 ACCESSION NUMBER: 0001209191-21-041176 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210614 FILED AS OF DATE: 20210616 DATE AS OF CHANGE: 20210616 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEVIN ARTHUR A CENTRAL INDEX KEY: 0001181556 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39321 FILM NUMBER: 211023049 MAIL ADDRESS: STREET 1: 1896 RUTHERFORD ROAD CITY: CARLSBAD STATE: CA ZIP: 92008 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Avidity Biosciences, Inc. CENTRAL INDEX KEY: 0001599901 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 461336960 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10975 N. TORREY PINES RD., STREET 2: #150 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 858-401-7900 MAIL ADDRESS: STREET 1: 10975 N. TORREY PINES RD., STREET 2: #150 CITY: LA JOLLA STATE: CA ZIP: 92037 FORMER COMPANY: FORMER CONFORMED NAME: Avidity Biosciences LLC DATE OF NAME CHANGE: 20161227 FORMER COMPANY: FORMER CONFORMED NAME: Avidity NanoMedicines LLC DATE OF NAME CHANGE: 20140211 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-06-14 0 0001599901 Avidity Biosciences, Inc. RNA 0001181556 LEVIN ARTHUR A C/O AVIDITY BIOSCIENCES, INC. 10975 N. TORREY PINES RD., SUITE 150 LA JOLLA CA 92037 0 1 0 0 Chief Scientific Officer Common Stock 2021-06-14 4 S 0 14003 25.9174 D 23019 I By charitable remainder trust Common Stock 2021-06-15 4 S 0 23019 26.0249 D 0 I By charitable remainder trust The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $25.70 to $26.06. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $25.62 to $26.47. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/ John W. Wallen III, Ph.D., J.D., Attorney-in-Fact 2021-06-16